Replies to post #609706 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

Market makers are ran by algorithms like all of Wall Street. The people you see on NYSE floor do not do anything. They're only there for television.

These algorithms are why the case will never go to trial. The defendants have too much to lose if their intellectual property gets leaked or if a whistleblower comes forward. The latter would be the worst possible outcome as the SEC are seeking to reform the market structure.

Guess what would be perfect justification for that change? A whistleblower who showcases how the business model of these market makers nearly destroyed a life-saving cancer company. The lawsuit by itself could have that impact if we get to discovery. This explains why defendants will settle after MTD denial.

I expect 1 billion plus settlement by Q2 2024 at the latest.